News

San Diego-based Allele Biotechnology and Pharmaceuticals, Inc., officially announced a joint research and development agreement with South Korea’s SCM Lifescience Co., Ltd., for the…
Read More...

DNAnexus, Inc., and the not-for-profit Sutter Health network announced the first large-scale clinico-genomic multiple sclerosis (MS) research study conducted by a leading healthcare…
Read More...

Enesi Pharma, an innovative pharmaceutical company developing unique injectable solid dose drug-device vaccine products, announces it has entered a public-private partnership with the…
Read More...

Pulmatrix and Cipla Technologies announced their entry into a Definitive Agreement for the co-development and commercialization of Pulmazole (PUR1900) – an inhaled iSPERSE formulation…
Read More...

Boehringer Ingelheim has acquired a minority stake in SoundTalks NV, a Belgian company. SoundTalks NV has developed a digital monitoring tool that seeks to improve the healthcare of…
Read More...

Catalent and Paragon Bioservices announced they have entered into a definitive agreement under which Catalent will acquire Paragon for $1.2 billion. “Paragon’s unparalleled expertise…
Read More...

Dr. Reddy’s Laboratories Ltd. announced that it has entered into a definitive agreement to acquire a portfolio of 42 approved, non-marketed Abbreviated New Drug Applications (ANDAs) in…
Read More...

Bristol-Myers Squibb Company announced that its shareholders voted to approve the issuance of shares of Bristol-Myers Squibb common stock in connection with the Company’s pending merger…
Read More...

AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) announced the European Commission has approved Lynparza (olaparib) as a…
Read More...

Sanofi and Alnylam have agreed to conclude the research and option phase of the companies’ 2014 RNAi therapeutics alliance in rare genetic diseases. The material collaboration terms for…
Read More...

Evotec SE and Indivumed GmbH announced that they have entered into a research collaboration to discover and develop first-in-class therapeutics for the treatment of colorectal cancer…
Read More...

Moleculin Biotech announced it has entered into an agreement with Emory University to conduct a Phase 1 clinical trial of WP1066 in children with recurrent or refractory malignant brain…
Read More...

Catalent Pharma Solutions announced the completion of its new, 30,000-square-foot clinical supply facility in Shanghai, China. The event was marked with an official opening ceremony at…
Read More...

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced a new collaboration with…
Read More...

FUJIFILM Diosynth Biotechnologies (Fujifilm), a leading Contract Development and Manufacturing Organization (CDMO) with experience in the development and manufacture of recombinant…
Read More...

Cryoport, Inc. announced it has been selected by Celularity to utilize its complete range of temperature-controlled solutions. Cryoport is the life sciences industry's foremost…
Read More...

Cambrex Corporation announced that it had completed the construction of a $24 million highly potent API (HPAPI) manufacturing facility at its site in Charles City, IA. The 6,000 sq. ft.…
Read More...

Pharmaceutical and biotechnology major Wockhardt has received approval from the United States Food & Drug Administration (US FDA) for an ANDA for 50mg injection of Decitabine, which…
Read More...

I-Mab Biopharma, a clinical stage biopharmaceutical company exclusively focused on the development of potential first-in-class and best-in-class biologics in immuno-oncology and…
Read More...

LEO Pharma A/S announced an expansion of the two companies' partnership agreement (signed in 2017) to further include antibodies from LEO Pharma's pipeline with the aim of achieving…
Read More...